semaglutide 2.4 mg brand name Wegovy® / 0.75 mL Injection 4 Use of semaglutide linked to
Description
No significant differences were observed in achieving LDL-cholesterol targets, although tirzepatide was superior in attaining triglyceride goals
As the surrogate endpoint examples underline, achieving a surrogate endpoint does not always lead to clinical benefit
GLP-1 , ,
2019 Feb 15: Accessed 2021 Mar 26
Both drugs use the active ingredient semaglutide
